Mobile Phone and Smartphone Technologies for Diabetes Care and Self-Management

Abstract

Mobile and smartphone (mHealth) technologies have the potential to improve diabetes care and self-management, but little is known about their effectiveness and how patients, providers, and payers currently interact with them. We conducted a systematic review and found only 20 peer-reviewed articles, published since 2010, with robust evidence about the effectiveness of mHealth interventions for diabetes. The majority of these interventions showed improvement on primary endpoints, such as HbA1c; mHealth technologies that interacted with both patients and providers were more likely to be effective. There was little evidence about persistent use by patients, use by a patient's health care provider, or long-term effectiveness. None of the studies discussed regulatory oversight of mHealth technologies or payer reimbursement for them. No robust studies evaluated the more than 1100 publicly available smartphone apps for diabetes. More research with valid study designs and longer follow-up is needed to evaluate the impact of mHealth technologies for diabetes care and self-management.

Technology in Diabetes and Diabetic Foot Education - Mobile Education

“…Yapılan başka bir çalışmada da, 2002-2015 yıllara arasında, diyabette bakıma yönelik geliş-tirilen mobil uygulamaları içeren 359 araştırma incelenmiştir. Sağlık teknolojilerinin, diyabetli bireylerin öz bakım davranışlarını, sağlık algılarını ve sağlığı yönetme biçimlerini pozitif yönde etkilediği sonucuna varılmıştır (36) . Baron ve arkadaşlarının (37) yaptığı bir sistematik derleme çalışmada da, literatüre paralel bulgular elde etmiş olup, 13 çalışma incelenmiş ve tip 2 diyabette mobil uygulamaların kullanılmasının yararlı olduğu vurgulanmıştır.…”

A Systematic Review of Literature Reporting on Studies Analysing Technologies for Ageing in Place to Support Community-Dwelling Older Adults

“…self-monitoring blood glucose recording, medication compliance, prandial insulin dose calculators, daily eating behaviours, physical activity and also integrated communication between patients and healthcare providers) (Baron, McBain and Newman, 2012;El-Gayar, Timsina, Nawar and Eid, 2013;Or and Tao, 2014;Garabedian, Ross-Degnan and Wharam, 2015), which impacts different outcomes: glycaemia by using glycosylated haemoglobin (HbA1c) as a proxy, physiological parameters (e.g. weight, depression, blood pressure, cholesterol level, triglycemius level, fluctuation index), health-related quality of life, behaviour outcomes (e.g.…”

“…weight, depression, blood pressure, cholesterol level, triglycemius level, fluctuation index), health-related quality of life, behaviour outcomes (e.g. diet and healthy eating or physical activity) (El-Gayar et al, 2013;Garabedian et al, 2015;Arambepola et al, 2016;Farmer et al, 2016), patient self-motivation, patient-clinician communication, medication adherence, and structural outcomes related to care coordination (Or and Tao, 2014;Garabedian et al, 2015;Arambepola et al, 2016).…”

Potential of Mobile Applications in Prevention and Management of Cardio-Metabolic Diseases

“…Most interventions using mobile apps showed positive outcomes especially on primary end points such as glycated haemoglobin (HbA1c). 20,21 Interventions that allow interaction between patients and providers were more likely to be effective, 20 while the visual reinforcement was identified as motivational. 22 Blood glucose recording and activity logs were the most common features of commercially available mobile apps for diabetes.…”